Pages

Tuesday, November 27, 2012

State closes deadly drug shipment misbranding case


Published 2:00 p.m., Tuesday, November 27, 2012
AUSTIN, Texas (AP) — The Texas attorney general's office has resolved its case against a Dallas-based mail-order compounding pharmacy over a shipment of a misbranded drug ingredient blamed for three Pacific Northwest deaths.
An attorney general's office statement Tuesday says pharmacist Gary Osborn and his companies, Apothecure Inc. and SpectraPharm Inc., will pay $200,000 to the state, including $100,000 in civil penalties. They also agree to compound drugs to order and in a legal manner.
Osborn and ApotheCure received probation and $100,000 fines after pleading guilty to two misdemeanor criminal violations of the federal Food, Drug and Cosmetic Act.
The cases center on a February 2007 shipment of a gout drug containing some vials with dosages more than seven times stronger than shown on the label. Autopsies showed three Oregon patients suffered fatal overdoses.


Read more: http://www.sfgate.com/news/texas/article/State-closes-deadly-drug-shipment-misbranding-case-4071164.php#ixzz2DTGehD3Y

No comments:

Post a Comment